News Letter to Shareholders and Corporate Update Continue Reading Previous Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offeringNext Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Related Stories Business Intelligence News NIQ and Consumer Technology Association Release 2025 Global Tech & Durables Outlook: Navigating a Year of Recovery and Intentional Spending News CES J-4: Don’t Miss a Major French Innovation! WASHIN Will Present NoLa at the Las Vegas 2025 CES in Preview News KB Home Announces the Grand Opening of Its Newest Community in Banning, California News Cleveland-Cliffs Appoints Jane Cronin to the Board of Directors News Cerence AI Expands Collaboration with NVIDIA to Advance its CaLLM Family of Language Models News Gill, Denson & Company Acquires RealValue Property Tax, Expanding Leadership in Property Tax Advisory